Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

Imagem de Miniatura
Arquivos
art_MURRAY_Global_regional_and_national_incidence_and_mortality_for_2014.PDF (33.81 MB)
Citações na Scopus
741
Tipo de produção
article
Data de publicação
2014
Editora
ELSEVIER SCIENCE INC
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
MURRAY, Christopher J. L.
ORTBLAD, Katrina F.
GUINOVART, Caterina
LIM, Stephen S.
WOLOCK, Timothy M.
ROBERTS, D. Allen
DANSEREAU, Emily A.
GRAETZ, Nicholas
BARBER, Ryan M.
BROWN, Jonathan C.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
LANCET, v.384, n.9947, p.1005-1070, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. Methods To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets. Findings Globally in 2013, there were 1.8 million new HIV infections (95% uncertainty interval 1.7 million to 2.1 million), 29.2 million prevalent HIV cases (28.1 to 31.7), and 1.3 million HIV deaths (1.3 to 1.5). At the peak of the epidemic in 2005, HIV caused 1.7 million deaths (1.6 million to 1.9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19.1 million life-years (16.6 million to 21.5 million) have been saved, 70.3% (65.4 to 76.1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7.5 million (7.4 million to 7.7 million), prevalence was 11.9 million (11.6 million to 12.2 million), and number of deaths was 1.4 million (1.3 million to 1.5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7.1 million (6.9 million to 7.3 million), prevalence was 11.2 million (10.8 million to 11.6 million), and number of deaths was 1.3 million (1.2 million to 1.4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64.0% of cases (63.6 to 64.3) and 64.7% of deaths (60.8 to 70.3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1.2 million deaths (1.1 million to 1.4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31.5% (15.7 to 44.1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. Interpretation Our estimates of the number of people living with HIV are 18.7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/8899
Referências
  1. Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1
  2. ALLEN S, 1992, AM REV RESPIR DIS, V146, P1439
  3. Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6
  4. Alliance NCD, 2014, TACKL NONC DIS ENH S
  5. ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E
  6. [Anonymous], 2011, TUB PREV SURV HDB
  7. Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca
  8. Atun R, 2010, LANCET, V376, P940, DOI 10.1016/S0140-6736(10)61428-6
  9. Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3
  10. Bates M, 2012, LANCET, V380, P560, DOI 10.1016/S0140-6736(12)61323-3
  11. Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335
  12. Bautista-Arredondo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072616
  13. Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0
  14. Birnbaum JK, 2011, B WORLD HEALTH ORGAN, V89, P278, DOI 10.2471/BLT.11.086280
  15. BRAUN MM, 1991, AM REV RESPIR DIS, V143, P501
  16. Brown T., 2006, Sexually Transmitted Infections, V82, P34
  17. Byass P, 2013, PLOS MED, V10
  18. Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
  19. Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
  20. Chambers RG, 2012, LANCET, V379, P707, DOI 10.1016/S0140-6736(12)60280-3
  21. Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436
  22. Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4
  23. Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20
  24. Clemens MA, 2007, WORLD DEV, V35, P735, DOI 10.1016/j.worlddev.2006.08.003
  25. Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1
  26. Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324
  27. Dabis F, 2005, AIDS, V19, P309
  28. DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0
  29. Darby SC, 1996, LANCET, V347, P1573
  30. Decker MR, 2014, AIDS BEHAV, V18, P562, DOI 10.1007/s10461-013-0577-y
  31. Degenhardt L, 2014, INT J DRUG POLICY, V25, P53, DOI 10.1016/j.drugpo.2013.08.004
  32. Department for International Development. UKAID, 2011, ZER INF UKS POS PAP
  33. Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432
  34. Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2
  35. Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453
  36. Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431
  37. Espinal MA, 2003, TUBERCULOSIS, V83, P44, DOI 10.1016/S1472-9792(02)00058-6
  38. Fehling M, 2013, GLOB PUBLIC HEALTH, V8, P1109, DOI 10.1080/17441692.2013.845676
  39. Ferreira MMC, 1996, J ACQ IMMUN DEF SYND, V13, P177
  40. Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7
  41. Floyd K, 2013, LANCET GLOB HEALTH, V1, pE105, DOI 10.1016/S2214-109X(13)70032-9
  42. Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1
  43. Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108
  44. Freguja R, 2012, NEW MICROBIOL, V35, P249
  45. Freguja R, 2012, AIDS, V26, P765, DOI 10.1097/QAD.0b013e3283514350
  46. Futures Institute, AIM COMP PROGR MAK H
  47. Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378
  48. Ghys PD, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000299404.99033.bf
  49. Ghys PD, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010199
  50. GIGLIOLI G, 1972, B WORLD HEALTH ORGAN, V46, P181
  51. Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247
  52. GRAY RH, 1974, POP STUD-J DEMOG, V28, P205, DOI 10.2307/2173955
  53. Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080
  54. Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290
  55. Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X
  56. Herbeck JT, 2010, J INFECT DIS, V201, P618, DOI 10.1086/649842
  57. Hewitt K, 2006, AIDS, V20, P1993, DOI 10.1097/01.aids.0000247572.95880.92
  58. Houben RMGJ, 2012, AIDS, V26, P2233, DOI 10.1097/QAD.0b013e32835958ed
  59. Institute for Health Metrics and Evaluation, 2013, FIN GLOB HLTH 2013 T
  60. Jackson DJ, 2007, AIDS, V21, P509, DOI 10.1097/QAD.0b013e32801424d2
  61. Keizer ST, 2000, J EPIDEMIOL COMMUN H, V54, P64, DOI 10.1136/jech.54.1.64
  62. Ki-moon B, 2011, SECRETARY GEN MESSAG
  63. Korenromp EL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-18
  64. LEROY V, 1995, J ACQ IMMUN DEF SYND, V9, P415
  65. Li DM, 2014, CHINESE MED J-PEKING, V127, P707, DOI 10.3760/cma.j.issn.0366-6999.20131502
  66. Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
  67. Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
  68. Lomazzi M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23695
  69. Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041
  70. Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
  71. Lynch M, 2012, LANCET, V380, P559, DOI 10.1016/S0140-6736(12)61320-8
  72. Makani J, 2003, QJM-INT J MED, V96, P355, DOI 10.1093/qjmed/hcg059
  73. Malaria Roll Back, 2010, MAL FUND RES UT 1 DE
  74. Mason K, 2013, AIDS RES HUM RETROV, V29, P1547, DOI [10.1089/AID.2013.0092, 10.1089/aid.2013.0092]
  75. Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2
  76. Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2
  77. McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073
  78. MEDICC, 2013, MEDICC REV, V15, P3
  79. Mehra M, 2013, INT J TUBERC LUNG D, V17, P1186, DOI 10.5588/ijtld.12.0959
  80. Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5
  81. Miller WM, 2013, SALUD PUBLICA MEXICO, V55, pS65
  82. Mpimbaza A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026892
  83. Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8
  84. Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
  85. Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6
  86. Murray CJL, 2012, LANCET, V380, P2055, DOI 10.1016/S0140-6736(12)62134-5
  87. Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5
  88. Nadjm B, 2012, T ROY SOC TROP MED H, V106, P688, DOI 10.1016/j.trstmh.2012.08.006
  89. Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9
  90. Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939
  91. Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9
  92. Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692
  93. Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0
  94. Nykanen M, 1995, E AFR MED J, V72, P731
  95. O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7
  96. Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14
  97. Papworth Erin, 2013, J Int AIDS Soc, V16 Suppl 3, P18751, DOI 10.7448/IAS.16.4.18751
  98. Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271
  99. Pretorius C, 2014, AIDS, V28, pS25, DOI 10.1097/QAD.0000000000000085
  100. Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476
  101. Reyburn H, 2004, BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55
  102. Ruan Y, 2013, SE ASIAN J TROP MED, V44, P842
  103. Sajadi L, 2013, SEX TRANSM INFECT, V89, P37, DOI 10.1136/sextrans-2013-051028
  104. Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
  105. Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0
  106. Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X
  107. Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x
  108. Shah NK, 2012, LANCET, V380, P560, DOI 10.1016/S0140-6736(12)61322-1
  109. Shah NK, 2011, LANCET, V377, P991, DOI 10.1016/S0140-6736(11)60378-4
  110. Shah NK, 2012, INDIAN J MED RES, V135, P270
  111. Shanks GD, 2008, LANCET INFECT DIS, V8, P564, DOI [10.1016/S1473-3099(08)70130-0, 10.1016/S473-3099(08)70130-0]
  112. Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045
  113. Simbayi L, 2014, S AFRICAN NATL HIV P
  114. Snow RW, 2003, 11 DCPP, P75
  115. Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142
  116. SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4
  117. Snow RW, 2010, LANCET, V376, P1409, DOI 10.1016/S0140-6736(10)61340-2
  118. Snow RW, 2004, AM J TROP MED HYG, V71, P16
  119. Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827
  120. South Africa Info Reporter, 2012, S AFR HIV AIDS BATTL
  121. Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299
  122. Stop TB, 2012, PARTN NO MOR CRYING
  123. Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640
  124. Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241
  125. The GBD 2013 Collaboration, 2013, GLOB REG NAT B UNPUB
  126. Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8
  127. TODD JE, 1994, ANN TROP PAEDIATR, V14, P31
  128. Treatment Action Group, 2012, ZER DECL
  129. Umunyana J, 2014, INCIDENCE MALARIA HI
  130. UNAIDS, 2007, 2007 AIDS EP UPD
  131. UNAIDS, 2013, METH UND HIV EST
  132. UNAIDS, 2010, 2011 2015 STRAT GETT
  133. UNAIDS, 2013, GLOB REP UNAIDS REP, P46
  134. UNAIDS. WHO, 2005, GUID MEAS NAT HIV PR
  135. United Nations, 2013, MILL DEV GOALS REP 2
  136. Vandemoortele J, 2010, IDS BULL-I DEV STUD, V41, P60
  137. Vassall A, 2013, LANCET GLOB HEALTH, V1, pE62, DOI 10.1016/S2214-109X(13)70044-5
  138. Verguet S, 2013, J INFECT DIS, V207, P72, DOI 10.1093/infdis/jis635
  139. Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT
  140. Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
  141. Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8
  142. Waddington C, 2005, TRENDS INT FUNDING M
  143. Wagstaff A., 2004, MILLENNIUM DEV GOALS
  144. Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X
  145. WEF Harvard School of Public Health, GLOBAL EC BURDEN NON
  146. White NJ, 2012, LANCET, V380, P559, DOI 10.1016/S0140-6736(12)61321-X
  147. WHO, 2004, CAS STUD EST HIV INF
  148. WHO, GLOB TUB CONTR 2010
  149. WHO, 2013, WORLD MALARIA REPORT 2013, P1
  150. WHO, WORLD MAL REP 2008
  151. WHO, 2012, Q A MAL MORT EST
  152. WHO Global Task Force on TB Impact Measurement, 2014, NAT TB PREV SURV
  153. World Health Organization, 2013, ROADM CHILDH TUB
  154. World Health Organization, 2011, BURD BEST BUYS RED E
  155. WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
  156. Yang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049526
  157. Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789
  158. Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/05
Artigos e Materiais de Revistas Científicas - ODS/10